Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works Mechanisms of resistance to cancer immunotherapy remain poorly understood. Lymphocyte activation gene–3 (LAG3) signaling is regulated...

Full description

Bibliographic Details
Main Authors: Andrews, Lawrence P, Somasundaram, Ashwin, Moskovitz, Jessica M, Szymczak-Workman, Andrea L, Liu, Chang, Cillo, Anthony R, Lin, Huang, Normolle, Daniel P, Moynihan, Kelly Dare, Taniuchi, Ichiro, Irvine, Darrell J, Kirkwood, John M, Lipson, Evan J, Ferris, Robert L, Bruno, Tullia C, Workman, Creg J, Vignali, Dario AA
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2021
Online Access:https://hdl.handle.net/1721.1/133023
_version_ 1826198593576370176
author Andrews, Lawrence P
Somasundaram, Ashwin
Moskovitz, Jessica M
Szymczak-Workman, Andrea L
Liu, Chang
Cillo, Anthony R
Lin, Huang
Normolle, Daniel P
Moynihan, Kelly Dare
Taniuchi, Ichiro
Irvine, Darrell J
Kirkwood, John M
Lipson, Evan J
Ferris, Robert L
Bruno, Tullia C
Workman, Creg J
Vignali, Dario AA
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Andrews, Lawrence P
Somasundaram, Ashwin
Moskovitz, Jessica M
Szymczak-Workman, Andrea L
Liu, Chang
Cillo, Anthony R
Lin, Huang
Normolle, Daniel P
Moynihan, Kelly Dare
Taniuchi, Ichiro
Irvine, Darrell J
Kirkwood, John M
Lipson, Evan J
Ferris, Robert L
Bruno, Tullia C
Workman, Creg J
Vignali, Dario AA
author_sort Andrews, Lawrence P
collection MIT
description Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works Mechanisms of resistance to cancer immunotherapy remain poorly understood. Lymphocyte activation gene–3 (LAG3) signaling is regulated by a disintegrin and metalloprotease domain-containing protein–10 (ADAM10)–and ADAM17-mediated cell surface shedding. Here, we show that mice expressing a metalloprotease-resistant, noncleavable LAG3 mutant (LAG3NC) are resistant to PD1 blockade and fail to mount an effective antitumor immune response. Expression of LAG3NC intrinsically perturbs CD4+ T conventional cells (Tconvs), limiting their capacity to provide CD8+ T cell help. Furthermore, the translational relevance for these observations is highlighted with an inverse correlation between high LAG3 and low ADAM10 expression on CD4+ Tconvs in the peripheral blood of patients with head and neck squamous cell carcinoma, which corresponded with poor prognosis. This correlation was also observed in a cohort of patients with skin cancers and was associated with increased disease progression after standard-of-care immunotherapy. These data suggest that subtle changes in LAG3 inhibitory receptor signaling can act as a resistance mechanism with a substantive effect on patient responsiveness to immunotherapy.
first_indexed 2024-09-23T11:07:13Z
format Article
id mit-1721.1/133023
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T11:07:13Z
publishDate 2021
publisher American Association for the Advancement of Science (AAAS)
record_format dspace
spelling mit-1721.1/1330232022-09-27T17:17:09Z Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding Andrews, Lawrence P Somasundaram, Ashwin Moskovitz, Jessica M Szymczak-Workman, Andrea L Liu, Chang Cillo, Anthony R Lin, Huang Normolle, Daniel P Moynihan, Kelly Dare Taniuchi, Ichiro Irvine, Darrell J Kirkwood, John M Lipson, Evan J Ferris, Robert L Bruno, Tullia C Workman, Creg J Vignali, Dario AA Massachusetts Institute of Technology. Department of Biological Engineering Koch Institute for Integrative Cancer Research at MIT Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works Mechanisms of resistance to cancer immunotherapy remain poorly understood. Lymphocyte activation gene–3 (LAG3) signaling is regulated by a disintegrin and metalloprotease domain-containing protein–10 (ADAM10)–and ADAM17-mediated cell surface shedding. Here, we show that mice expressing a metalloprotease-resistant, noncleavable LAG3 mutant (LAG3NC) are resistant to PD1 blockade and fail to mount an effective antitumor immune response. Expression of LAG3NC intrinsically perturbs CD4+ T conventional cells (Tconvs), limiting their capacity to provide CD8+ T cell help. Furthermore, the translational relevance for these observations is highlighted with an inverse correlation between high LAG3 and low ADAM10 expression on CD4+ Tconvs in the peripheral blood of patients with head and neck squamous cell carcinoma, which corresponded with poor prognosis. This correlation was also observed in a cohort of patients with skin cancers and was associated with increased disease progression after standard-of-care immunotherapy. These data suggest that subtle changes in LAG3 inhibitory receptor signaling can act as a resistance mechanism with a substantive effect on patient responsiveness to immunotherapy. NIH (Grant EB022433) 2021-10-18T14:57:59Z 2021-10-18T14:57:59Z 2020 2021-09-03T17:06:04Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/133023 Andrews, Lawrence P, Somasundaram, Ashwin, Moskovitz, Jessica M, Szymczak-Workman, Andrea L, Liu, Chang et al. 2020. "Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding." Science Immunology, 5 (49). en 10.1126/SCIIMMUNOL.ABC2728 Science Immunology Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf American Association for the Advancement of Science (AAAS) PMC
spellingShingle Andrews, Lawrence P
Somasundaram, Ashwin
Moskovitz, Jessica M
Szymczak-Workman, Andrea L
Liu, Chang
Cillo, Anthony R
Lin, Huang
Normolle, Daniel P
Moynihan, Kelly Dare
Taniuchi, Ichiro
Irvine, Darrell J
Kirkwood, John M
Lipson, Evan J
Ferris, Robert L
Bruno, Tullia C
Workman, Creg J
Vignali, Dario AA
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
title Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
title_full Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
title_fullStr Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
title_full_unstemmed Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
title_short Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
title_sort resistance to pd1 blockade in the absence of metalloprotease mediated lag3 shedding
url https://hdl.handle.net/1721.1/133023
work_keys_str_mv AT andrewslawrencep resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT somasundaramashwin resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT moskovitzjessicam resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT szymczakworkmanandreal resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT liuchang resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT cilloanthonyr resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT linhuang resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT normolledanielp resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT moynihankellydare resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT taniuchiichiro resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT irvinedarrellj resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT kirkwoodjohnm resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT lipsonevanj resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT ferrisrobertl resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT brunotulliac resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT workmancregj resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding
AT vignalidarioaa resistancetopd1blockadeintheabsenceofmetalloproteasemediatedlag3shedding